Metabolic-Fit / 100
ReadyRx review
A broader wellness platform with GLP-1s starting from $179/mo semaglutide and $255/mo tirzepatide, alongside a longevity catalog — though the 'From' pricing means the real ongoing cost isn't fully confirmed, and there's no postpartum or PCOS-specific content anywhere on the site's public pages, which is worth knowing before you start.
- HSA / FSA-eligible
- Editor-vetted
- No insurance needed
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Every clinical figure in this piece is cited inline to its primary source — the trial or the FDA label — so you can open it and check us. This is background reading, not medical advice.
ReadyRx at a glance
- Semaglutide
- From $179/mo
- Tirzepatide
- From $255/mo
- Coverage
- Nationwide
- Brand-name
- Compounded only
How we scored ReadyRx
Every factor comes from ReadyRx's own published pricing, disclosures and oversight, and the six combine into the 50/100 Metabolic-Fit Score by the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
No postpartum or breastfeeding framing — a generic weight program.
Thin on the hormonal picture that drives many mothers' weight.
Oversight and lab support fall short of the top of this roster — the review below says exactly where.
Cost is unpredictable or sits at the premium end.
Support is thin once the prescription ships.
Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.
How we verified this review
- Last verified
- August 2026
- Confidence
- medium
- Primary source
- www.readyrx.com
$179 for semaglutide and $255 for tirzepatide, both confirmed on ReadyRx's homepage and both framed as 'from' rather than as a rate. What a given dose or plan length actually costs beyond that entry figure is not published, so settle it before the first charge.
What to expect when you sign up
We walked ReadyRx's public signup funnel (August 2026) — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
- 1The homepage lists both molecules with 'From $X/mo' pricing directly, alongside several longevity add-ons (Sermorelin, NAD+, Glutathione, MIC+B12, Metformin)
- 2A roughly 2-minute online assessment determines eligibility, per the site's own claim
- 3Site states 15,000+ members and a doctor-led, community-support model
What we noticed
- Both core GLP-1 prices are visible on the homepage without starting an intake, though the 'From' framing means the exact price at your dose isn't confirmed until later in the funnel
- A broader longevity catalog beyond GLP-1s (Sermorelin, NAD+, Glutathione, MIC+B12) is offered on the same platform
- No mention anywhere of pregnancy, breastfeeding, postpartum care, or PCOS
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $179 | From (entry tier)Listed as 'From $179/mo' — likely a starting tier; exact plan-length or dose breakdown not itemized on the pages checked. |
| Compounded tirzepatide | $255 | From (entry tier)Listed as 'From $255/mo' — likely a starting tier; exact plan-length or dose breakdown not itemized on the pages checked. |
Swipe the table to see plan details →
Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what ReadyRx's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.
What we like
- Both core GLP-1 prices visible directly on the homepage, no intake required to see a starting number
- Broader catalog (Sermorelin, NAD+, Glutathione, MIC+B12, Metformin) for readers interested beyond GLP-1s
- Claims 15,000+ members and a doctor-led, community-support model
The caveats
- Pricing is framed as 'From' — the exact ongoing monthly cost at a given dose wasn't itemized on the pages checked
- No mention anywhere of pregnancy, breastfeeding, postpartum care, or PCOS
- No brand-name (FDA-approved) option and no oral form
- No named compounding pharmacy or medical director found on the site
ReadyRx for mothers: our verdict
A broader wellness platform with GLP-1s starting from $179/mo semaglutide and $255/mo tirzepatide, alongside a longevity catalog — though the 'From' pricing means the real ongoing cost isn't fully confirmed, and there's no postpartum or PCOS-specific content anywhere on the site's public pages, which is worth knowing before you start. It runs about $179/month.
We weigh ReadyRx the way mothers actually have to: not just the monthly cost, but postpartum and breastfeeding timing and PCOS and insulin resistance — the parts a general weight-loss roundup leaves out.
What ReadyRx costs, in full
- Compounded semaglutide — From (entry tier): $179/mo
- Compounded tirzepatide — From (entry tier): $255/mo
That lands within a few dollars of the ~$179/month median across the providers we track, so the monthly cost isn't what should decide this one either way. Weigh it instead on postpartum and breastfeeding timing and PCOS and insulin resistance, and on what the price actually includes — a lower number that leaves out labs, visits or shipping is not the cheaper option.
On that last point ReadyRx is no help: it doesn't break down what the monthly figure covers — whether the provider visit, shipping and any lab work are inside it or billed separately. Ask before you pay, because that answer is what decides whether a mid-range price is actually mid-range.
The medications ReadyRx prescribes
ReadyRx prescribes semaglutide and tirzepatide — the two with the largest published weight-loss effects, and carrying both on one account matters when insulin resistance, common with PCOS and after gestational diabetes, makes tirzepatide the better-suited option. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.
Where ReadyRx fits — and where it doesn't — for mothers
A good fit if…
- the monthly cost is a real barrier and you want a low, predictable number.
- switching between semaglutide and tirzepatide may become necessary as your body and your hormones change.
Look elsewhere if…
- you specifically want an FDA-approved brand pen with its own pregnancy and lactation labeling.
- you'd rather a prescriber talk through timing around postpartum and breastfeeding timing — that is the ground our #1 pick, CoreAge Rx, is built on.
Oversight, safety, and what we could verify
Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.
One line that applies to every provider on this site: no GLP-1 is established as safe in pregnancy or while breastfeeding, and the labels advise against use. This is a review of a commercial program, not a green light — the timing decision belongs to you and your clinician.
The bottom line
ReadyRx is a reasonable option — weigh it on postpartum and breastfeeding timing and PCOS and insulin resistance against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: Mothers interested in GLP-1s alongside a broader longevity and wellness catalog on one platform.
Alternatives to ReadyRx
Providers we have a referral relationship with, ordered by their Metabolic-Fit Score — highest first. This module leaves out the provider whose page you are reading, so on CoreAge Rx's own review our #1 pick is the one name you will not find here. These are not the whole roster: see the full ranking for every provider we cover, paid or not.
- Visit CoreAge Rx92
Metabolic-Fit / 100
CoreAge RxOur #1 pickOne flat price, both molecules on a single chart, and a prescriber who reads your history before writing — the most predictable place for a mother to start and, just as important, to pause.
- Visit Gala Health84
Metabolic-Fit / 100
A flat $179 for either molecule with a genuinely gentle microdosing tier — a reasonable, all-doses-included option if you can live with a yearly plan and a pharmacy it doesn't name.
- Visit Enhance MD81
Metabolic-Fit / 100
One of the more oversight-forward compounded programs here — lab work and a live provider visit bundled into every plan, with a gentle microdosing tier — the catch is that the low '$212' headline you'll see quoted is the 12-month prepay rate, not the $249 you'd pay month to month.
Keep comparing ReadyRx
Head-to-head & alternatives
ReadyRx, answered
- How much does ReadyRx cost?
- At last review, ReadyRx's lowest ongoing compounded rate was about $179 a month — From $179/mo for semaglutide, From $255/mo for tirzepatide. This market re-prices often, so check the current all-in figure at the source before committing.
- Is ReadyRx safe to use while breastfeeding?
- Nothing in this class — compounded or brand — has been established as safe in pregnancy or lactation, and every label advises against use. ReadyRx is not an exception to that. Plan a GLP-1 for after weaning and settle the timing with your own clinician.
- Does ReadyRx offer both semaglutide and tirzepatide?
- Yes — ReadyRx offers both molecules. Tirzepatide's dual GIP/GLP-1 action is often preferred where insulin resistance drives weight, which matters for PCOS and after gestational diabetes.
- Where does ReadyRx rank for mothers?
- ReadyRx scores 50/100 on our Metabolic-Fit Score and sits at #96. That score is a weighted read of six things mothers actually have to care about. CoreAge Rx currently leads it — see how they compare.
Pricing, states and verification reflect ReadyRx's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.